Biosimilars versus the originator of follitropin alfa: Randomized controlled trials are still the best way to evaluate their comparative effectiveness in assisted reproduction

Christos A. Venetis* (Corresponding Author), Ben W. Mol

*Corresponding author for this work

Research output: Contribution to journal › Editorial › peer-review

1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'Biosimilars versus the originator of follitropin alfa: Randomized controlled trials are still the best way to evaluate their comparative effectiveness in assisted reproduction'. Together they form a unique fingerprint.

Medicine & Life Sciences